Novel molecular biomarkers of cancer therapy‐induced cardiotoxicity in adult population: a scoping review-Reference-Cited by-同舟云学术

Novel molecular biomarkers of cancer therapy‐induced cardiotoxicity in adult population: a scoping review

Published:2022-03-08 Issue:3 Volume:9 Page:1651-1665
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Cartas‐Espinel Irene¹,Telechea‐Fernández Marcelino²,Manterola Delgado Carlos³⁴⁵,Ávila Barrera Andrés⁶,Saavedra Cuevas Nicolás⁷,Riffo‐Campos Angela L.⁵⁸^ORCID

Affiliation:

1. Programa de Doctorado en Ciencias mención Biología Celular y Molecular Aplicada Universidad de La Frontera Temuco Chile

2. Departamento de Fisiología Universidad de Valencia Valencia Spain

3. Departamento de Cirugía Universidad de La Frontera Temuco Chile

4. Centro de Excelencia en Estudios Morfológicos y Quirúrgicos (CEMyQ) Universidad de La Frontera Temuco Chile

5. Programa de Doctorado en Ciencias Médicas Universidad de La Frontera Temuco Chile

6. Centro de Excelencia de Modelación y Computación Científica Universidad de La Frontera Temuco Chile

7. Departamento de Ciencias Básicas Universidad de La Frontera Temuco Chile

8. Vicerrectoría Académica Universidad de La Frontera Temuco Chile

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.13735

Reference76 articles.

1. Precision cardio-oncology: understanding the cardiotoxicity of cancer therapy

2. Preventive Cardio-Oncology: The Time Has Come

3. Management and research in cancer treatment-related cardiovascular toxicity: Challenges and perspectives

4. A population-based study of cardiovascular disease mortality risk in US cancer patients

5. Cardio‐oncology discipline: focus on the necessities in developing countries

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypothesis paper: GDF15 demonstrated promising potential in Cancer diagnosis and correlated with cardiac biomarkers;Cardio-Oncology;2024-09-04

2. Early detection of anthracycline-induced cardiotoxicity using [68 Ga]Ga-FAPI-04 imaging;European Journal of Nuclear Medicine and Molecular Imaging;2024-03-16

3. Cardiovascular Biomarkers in Cardio-Oncology: Antineoplastic Drug Cardiotoxicity and Beyond;Biomolecules;2024-02-07

4. Harnessing iPSCs to Dissect Causality in Anthracycline-Induced Cardiotoxicity;JACC: CardioOncology;2024-02

5. CVD phenotyping in oncologic disorders: cardio-miRNAs as a potential target to improve individual outcomes in revers cardio-oncology;Journal of Translational Medicine;2024-01-12